Thrombin Cleaves Recombinant Human Thrombopoietin: One of the Proteolytic Events That Generates Truncated Forms of Thrombopoietin

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1997 Apr 29

PMID 9114049

Citations 4

Authors

T Kato

A Oda

Y Inagaki

H Ohashi

A Matsumoto

K Ozaki

Y Miyakawa

H Watarai

K Fuju

A Kokubo

T Kadoya

Y Ikeda

H Miyazaki

Affiliations

Soon will be listed here.

Abstract

A heterogeneity in the molecular weight (Mr) of thrombopoietin (TPO) has been reported. We found several thrombin cleavage sites in human, rat, murine, and canine TPOs, and also found that human TPO undergoes selective proteolysis by thrombin. Recombinant human TPO (rhTPO) was incubated with human platelets in the presence of calcium ions to allow the generation of thrombin, and was cleaved into low Mr peptide fragments. The cleavage was completely inhibited by hirudin, indicating that the proteolysis was mediated by thrombin. In a platelet-free system, analyses of thrombin cleavage by immunoblotting using anti-human TPO peptide antibodies revealed that the four major thrombin-cleaved peptide fragments were selectively generated depending on the digestion time. The amino acid sequences of the thrombin-polypeptides were further analyzed, and two major thrombin cleavage sites were determined. One of them was at AR191-T192 in the C-terminal domain of TPO, and thrombin cleaved first at this site. The other site at GR117-T118 in the N-terminal domain was subsequently cleaved by prolonged thrombin digestion. As a result, the biological activity of TPO was modulated. The generation of truncated forms of TPO by thrombin may be a notable event in view of the platelet-related metabolism of TPO.

Citing Articles

Thrombopoietin induces production of nucleated thrombocytes from liver cells in Xenopus laevis.

Tanizaki Y, Ichisugi M, Obuchi-Shimoji M, Ishida-Iwata T, Tahara-Mogi A, Meguro-Ishikawa M Sci Rep. 2015; 5:18519.

PMID: 26687619 PMC: 4685256. DOI: 10.1038/srep18519.

The biology of thrombopoietin and thrombopoietin receptor agonists.

Kuter D Int J Hematol. 2013; 98(1):10-23.

PMID: 23821332 DOI: 10.1007/s12185-013-1382-0.

Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Feese M, Tamada T, Kato Y, Maeda Y, Hirose M, Matsukura Y Proc Natl Acad Sci U S A. 2004; 101(7):1816-21.

PMID: 14769915 PMC: 357010. DOI: 10.1073/pnas.0308530100.

An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles.

Thomas J, Olson J, Tapscott S, Zhao L Genome Res. 2001; 11(7):1227-36.

PMID: 11435405 PMC: 311075. DOI: 10.1101/gr.165101.

References

Kato T, Ogami K, Shimada Y, Iwamatsu A, Sohma Y, Akahori H . Purification and characterization of thrombopoietin. J Biochem. 1995; 118(1):229-36. DOI: 10.1093/oxfordjournals.jbchem.a124883. View

Ogami K, Shimada Y, Sohma Y, Akahori H, Kato T, Kawamura K . The sequence of a rat cDNA encoding thrombopoietin. Gene. 1995; 158(2):309-10. DOI: 10.1016/0378-1119(95)00125-p. View

Miyakawa Y, Oda A, Druker B, Miyazaki H, Handa M, Ohashi H . Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood. 1996; 87(2):439-46. View

Fielder P, Gurney A, Stefanich E, Marian M, Moore M, de Sauvage F . Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 1996; 87(6):2154-61. View

Oda A, Miyakawa Y, Druker B, Ozaki K, Yabusaki K, Shirasawa Y . Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood. 1996; 87(11):4664-70. View

Tahara T, Usuki K, Sato H, Ohashi H, Morita H, Tsumura H . A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematol. 1996; 93(4):783-8. DOI: 10.1046/j.1365-2141.1996.d01-1741.x. View

Oda A, Ozaki K, Druker B, Miyakawa Y, Miyazaki H, Handa M . p120c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin. Blood. 1996; 88(4):1330-8. View

Morita H, Tahara T, Matsumoto A, Kato T, Miyazaki H, Ohashi H . Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Lett. 1996; 395(2-3):228-34. DOI: 10.1016/0014-5793(96)01047-2. View

Kato T . Protein characteristics of thrombopoietin. Stem Cells. 1996; 14 Suppl 1:139-47. DOI: 10.1002/stem.5530140718. View

10.

Brown J, Baugh R, Hougie C . The inhibition of the intrinsic generation of activated factor X by heparin and hirudin. Thromb Res. 1980; 17(1-2):267-72. DOI: 10.1016/0049-3848(80)90314-x. View

11.

Chang J . Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate. Eur J Biochem. 1985; 151(2):217-24. DOI: 10.1111/j.1432-1033.1985.tb09091.x. View

12.

Tam J . Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci U S A. 1988; 85(15):5409-13. PMC: 281766. DOI: 10.1073/pnas.85.15.5409. View

13.

Chang J . The hirudin-binding site of human alpha-thrombin. Identification of lysyl residues which participate in the combining site of hirudin-thrombin complex. J Biol Chem. 1989; 264(13):7141-6. View

14.

Hunt P, Hokom M, Wiemann B, Leven R, Arakawa T . Megakaryocyte proplatelet-like process formation in vitro is inhibited by serum prothrombin, a process which is blocked by matrix-bound glycosaminoglycans. Exp Hematol. 1993; 21(2):372-81. View

15.

Cohen S, Michaud D . Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal Biochem. 1993; 211(2):279-87. DOI: 10.1006/abio.1993.1270. View

16.

Boissel J, Lee W, Presnell S, Cohen F, BUNN H . Erythropoietin structure-function relationships. Mutant proteins that test a model of tertiary structure. J Biol Chem. 1993; 268(21):15983-93. View

17.

Vittet D, Chevillard C . Thrombin interactions with cells of the megakaryocytic lineage. Blood Coagul Fibrinolysis. 1993; 4(5):759-68. View

18.

de Sauvage F, Hass P, Spencer S, Malloy B, Gurney A, Spencer S . Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369(6481):533-8. DOI: 10.1038/369533a0. View

19.

Lok S, Kaushansky K, Holly R, Kuijper J, Oort P, Grant F . Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994; 369(6481):565-8. DOI: 10.1038/369565a0. View

20.

BARTLEY T, Bogenberger J, Hunt P, Li Y, Lu H, Martin F . Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 1994; 77(7):1117-24. DOI: 10.1016/0092-8674(94)90450-2. View